Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DFTX
DFTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DFTX News
Rapid Growth in Major Depressive Disorder Treatment Market
Jun 30 2026
Newsfilter
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Helus Pharma's HLP003 Phase 3 Trial Enrollment Surpasses 86%
Jun 26 2026
PRnewswire
Helus Pharma's HLP003 Phase 3 Trial Surpasses 86% Enrollment
Jun 26 2026
Newsfilter
Definium Therapeutics Prices $700 Million Public Offering for Psychiatric Drug Development
Jun 24 2026
NASDAQ.COM
Definium Therapeutics Prices $700M Public Offering of Common Shares
Jun 24 2026
seekingalpha
Definium Therapeutics Prices Public Offering at $34 per Share
Jun 24 2026
Newsfilter
Definium Therapeutics Raises $700 Million in Public Offering
Jun 24 2026
Yahoo Finance
Definium Therapeutics Stock Soars After Positive Trial Results
Jun 23 2026
Yahoo Finance
Definium Reports Positive Trial Results, Stock Soars
Jun 23 2026
stocktwits
Definium Reports Positive Trial Results for DT120
Jun 23 2026
Yahoo Finance
Mixed Market Close: Tech Stocks Decline Amid Leadership Changes
Jun 22 2026
NASDAQ.COM
Definium Therapeutics Announces $500M Public Offering
Jun 22 2026
seekingalpha
High Options Trading Volume for GE Vernova and Argan
Jun 22 2026
NASDAQ.COM
Mixed U.S. Stock Performance with Tech Stocks Leading Declines
Jun 22 2026
NASDAQ.COM
Definium Therapeutics' DT120 Drug Phase 3 Trial Success
Jun 22 2026
NASDAQ.COM
Show More News
